HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:HIVE - CA4339211035 - Common Stock
4.35 CAD
+0.01 (+0.23%)
Overall HIVE gets a fundamental rating of 4 out of 10. We evaluated HIVE against 66 industry peers in the Software industry. While HIVE seems to be doing ok healthwise, there are quite some concerns on its profitability. HIVE shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year HIVE was profitable.
In the past year HIVE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: HIVE reported negative net income in multiple years.
Each year in the past 5 years HIVE had a positive operating cash flow.
1.2 Ratios
HIVE's Return On Assets of 2.98% is fine compared to the rest of the industry. HIVE outperforms 73.44% of its industry peers.
With a decent Return On Equity value of 3.30%, HIVE is doing good in the industry, outperforming 73.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.98% | ||
| ROE | 3.3% | ||
| ROIC | N/A |
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIVE has a Profit Margin of 10.67%. This is amongst the best in the industry. HIVE outperforms 85.94% of its industry peers.
HIVE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 10.67% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HIVE has more shares outstanding
The number of shares outstanding for HIVE has been increased compared to 5 years ago.
Compared to 1 year ago, HIVE has an improved debt to assets ratio.
2.2 Solvency
HIVE has an Altman-Z score of 6.12. This indicates that HIVE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.12, HIVE belongs to the top of the industry, outperforming 82.81% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that HIVE is not too dependend on debt financing.
HIVE has a better Debt to Equity ratio (0.03) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.12 |
ROIC/WACCN/A
WACC9.92%
2.3 Liquidity
A Current Ratio of 2.55 indicates that HIVE has no problem at all paying its short term obligations.
HIVE has a Current ratio of 2.55. This is in the better half of the industry: HIVE outperforms 73.44% of its industry peers.
HIVE has a Quick Ratio of 2.55. This indicates that HIVE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HIVE (2.55) is better than 73.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.55 | ||
| Quick Ratio | 2.55 |
3. Growth
3.1 Past
HIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 301.67%, which is quite impressive.
The Revenue has grown by 57.09% in the past year. This is a very strong growth!
The Revenue has been growing by 31.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)301.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.09%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%285.26%
3.2 Future
Based on estimates for the next years, HIVE will show a very negative growth in Earnings Per Share. The EPS will decrease by -154.47% on average per year.
Based on estimates for the next years, HIVE will show a very strong growth in Revenue. The Revenue will grow by 70.47% on average per year.
EPS Next Y-467.04%
EPS Next 2Y127.8%
EPS Next 3Y-154.47%
EPS Next 5YN/A
Revenue Next Year182.4%
Revenue Next 2Y102.05%
Revenue Next 3Y70.47%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.59, the valuation of HIVE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of HIVE indicates a rather cheap valuation: HIVE is cheaper than 84.38% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of HIVE to the average of the S&P500 Index (27.19), we can say HIVE is valued inline with the index average.
With a Price/Forward Earnings ratio of 51.79, HIVE can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HIVE indicates a somewhat cheap valuation: HIVE is cheaper than 65.63% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HIVE to the average of the S&P500 Index (23.88), we can say HIVE is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.59 | ||
| Fwd PE | 51.79 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIVE indicates a somewhat cheap valuation: HIVE is cheaper than 68.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 22.92 |
4.3 Compensation for Growth
HIVE's earnings are expected to decrease with -154.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y127.8%
EPS Next 3Y-154.47%
5. Dividend
5.1 Amount
HIVE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:HIVE (1/9/2026, 7:00:00 PM)
4.35
+0.01 (+0.23%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners25.21%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.03B
Revenue(TTM)193.25M
Net Income(TTM)20.63M
Analysts80
Price Target9.05 (108.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)92.46%
Min EPS beat(2)-84.82%
Max EPS beat(2)269.73%
EPS beat(4)3
Avg EPS beat(4)98.81%
Min EPS beat(4)-84.82%
Max EPS beat(4)269.73%
EPS beat(8)7
Avg EPS beat(8)83.97%
EPS beat(12)8
Avg EPS beat(12)5.52%
EPS beat(16)10
Avg EPS beat(16)-99.68%
Revenue beat(2)2
Avg Revenue beat(2)10.1%
Min Revenue beat(2)3.29%
Max Revenue beat(2)16.9%
Revenue beat(4)3
Avg Revenue beat(4)6.2%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)16.9%
Revenue beat(8)6
Avg Revenue beat(8)6.47%
Revenue beat(12)9
Avg Revenue beat(12)6.95%
Revenue beat(16)12
Avg Revenue beat(16)15.9%
PT rev (1m)26.79%
PT rev (3m)44.9%
EPS NQ rev (1m)7.5%
EPS NQ rev (3m)-73.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-191.43%
Revenue NQ rev (1m)1.09%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.59 | ||
| Fwd PE | 51.79 | ||
| P/S | 3.86 | ||
| P/FCF | N/A | ||
| P/OCF | 35.07 | ||
| P/B | 1.19 | ||
| P/tB | 1.19 | ||
| EV/EBITDA | 22.92 |
EPS(TTM)0.17
EY3.91%
EPS(NY)0.08
Fwd EY1.93%
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)0.12
OCFY2.85%
SpS1.13
BVpS3.64
TBVpS3.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.98% | ||
| ROE | 3.3% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 10.67% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 161.26% | ||
| Cap/Sales | 79.14% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 75.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.55 | ||
| Quick Ratio | 2.55 | ||
| Altman-Z | 6.12 |
F-Score6
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)97.27%
Cap/Depr(5y)157.57%
Cap/Sales(3y)54.64%
Cap/Sales(5y)58.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)301.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-467.04%
EPS Next 2Y127.8%
EPS Next 3Y-154.47%
EPS Next 5YN/A
Revenue 1Y (TTM)57.09%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%285.26%
Revenue Next Year182.4%
Revenue Next 2Y102.05%
Revenue Next 3Y70.47%
Revenue Next 5YN/A
EBIT growth 1Y-66.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year327.7%
EBIT Next 3Y75.96%
EBIT Next 5YN/A
FCF growth 1Y-521.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.27%
OCF growth 3Y-36.92%
OCF growth 5Y84.91%
HIVE DIGITAL TECHNOLOGIES LT / HIVE.CA FAQ
Can you provide the ChartMill fundamental rating for HIVE DIGITAL TECHNOLOGIES LT?
ChartMill assigns a fundamental rating of 4 / 10 to HIVE.CA.
Can you provide the valuation status for HIVE DIGITAL TECHNOLOGIES LT?
ChartMill assigns a valuation rating of 2 / 10 to HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA). This can be considered as Overvalued.
Can you provide the profitability details for HIVE DIGITAL TECHNOLOGIES LT?
HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) has a profitability rating of 3 / 10.
What is the valuation of HIVE DIGITAL TECHNOLOGIES LT based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) is 25.59 and the Price/Book (PB) ratio is 1.19.
What is the earnings growth outlook for HIVE DIGITAL TECHNOLOGIES LT?
The Earnings per Share (EPS) of HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) is expected to decline by -467.04% in the next year.